期刊
JOURNAL OF WOMENS HEALTH
卷 14, 期 3, 页码 253-262出版社
MARY ANN LIEBERT, INC
DOI: 10.1089/jwh.2005.14.253
关键词
-
类别
资金
- NCRR NIH HHS [M01 RR10732] Funding Source: Medline
Background: Increased consumption of soy foods has been associated with reduction in low-density lipoprotein cholesterol (LDL-C) in both clinical and observational studies. However, it is not clear whether adding soy to a low-fat diet has additional lipid-lowering benefits, and few previous studies have examined these effects in women using hormone replacement therapy ( HRT+). Methods: We tested whether adding soy protein to a low-fat, high-fiber, Step I diet improved cardiac risk markers in 18 postmenopausal women and 14 men with hypercholesterolemia and examined whether concurrent use of HRT altered diet responsiveness. Diets were matched for macronutrient content, and all food was provided. After 3 weeks on the Step I diet, subjects were randomized to diets ( 6 weeks) containing 25 g/day protein isolate from soy or cow's milk, with crossover. The soy treatment contained 90 mg/day isoflavones. Lipids, vascular cell adhesion molecule-1 (VCAM-1), p-selectin, and urinary isoflavonoids were measured at the end of each diet. Results: In men and HRT- women only, there were significant reductions in LDL-C ( - 17.3%), high-density lipoprotein cholesterol (HDL-C) ( - 15.3%), and triglycerides ( - 11.5%) during the Step I diet, and soy had no additional effects. At study entry, HRT+ women had lower LDL-C and higher triglycerides than men. Their LDL-C was unchanged, and triglycerides were significantly reduced ( - 15.1%) by the Step I diets. Isoflavonoid excretion was unrelated to diet response or HRT status. Conclusions: In men and HRT- women, the diets significantly lowered LDL-C, independent of soy intake. In HRT- women, the diets improved triglycerides without lowering HDL-C.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据